NCT02312882View on ClinicalTrials.gov

Tofacitinib for the Treatment of Alopecia Areata and Its Variants

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Alopecia AreataAlopecia TotalisAlopecia Universalis
Interventions
DRUG

Tofacitinib

Tofacitinib 5 mg tablet taken by mouth twice a day.

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT02312882 - Tofacitinib for the Treatment of Alopecia Areata and Its Variants | Biotech Hunter | Biotech Hunter